Article
Targeting the DNA damage response network as a therapeutical strategy in ovarian and pancreatic cancers
2015-01-01
Abstract excerpt
High grade serous (HGS) epithelial ovarian cancer (EOC) and pancreatic ductal adenocarcinoma (PDAC) are among the poorest prognosis neoplasms; both are characterised by defects in DNA damage repair mechanisms, high levels of genomic instability, intra-tumoural heterogeneity and resistance, intrinsic or acquired, to conventional chemotherapy. The DNA damaging agents, gemcitabine and platinum are standard treatments...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4de21c98-922e-511a-b4c7-cdd2085b6c4b
- DOI
- 10.25560/29843
